A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome
A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome
Recruiting · NCT07675746 · Registry updated 2026-06-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome | Epilepsies, Myoclonic, Epilepsy, Generalized, Epileptic Syndromes, brain disorder, central nervous system disorder, epilepsy, generalized epilepsy with febrile seizures plus, type 2, nervous system disorder | Recruiting | Early phase 1 | 2026-06-30 | NCT07675746 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| RecoRNA(Guangzhou) Biotechnology Co., Ltd | 1 |
| Second Affiliated Hospital of Guangzhou Medical University | 70 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Second Affiliated Hospital of Guangzhou Medical University | Guangzhou | China | 1 |